- Home
- DARE vs KZR Comparison
DARE vs KZR Comparison
Compare DARE & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- KZR
- Stock Information
- Founded
- DARE 2015
- KZR 2015
- Country
- DARE United States
- KZR United States
- Employees
- DARE N/A
- KZR N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- DARE Health Care
- KZR Health Care
- Exchange
- DARE Nasdaq
- KZR Nasdaq
- Market Cap
- DARE 28.6M
- KZR 29.7M
- IPO Year
- DARE N/A
- KZR 2018
- Fundamental
- Price
- DARE $2.05
- KZR $6.28
- Analyst Decision
- DARE Strong Buy
- KZR Hold
- Analyst Count
- DARE 2
- KZR 4
- Target Price
- DARE $10.00
- KZR $6.00
- AVG Volume (30 Days)
- DARE 197.7K
- KZR 433.0K
- Earning Date
- DARE 11-13-2025
- KZR 11-11-2025
- Dividend Yield
- DARE N/A
- KZR N/A
- EPS Growth
- DARE N/A
- KZR N/A
- EPS
- DARE N/A
- KZR N/A
- Revenue
- DARE N/A
- KZR N/A
- Revenue This Year
- DARE $6,864.02
- KZR N/A
- Revenue Next Year
- DARE $4,922.46
- KZR N/A
- P/E Ratio
- DARE N/A
- KZR N/A
- Revenue Growth
- DARE N/A
- KZR N/A
- 52 Week Low
- DARE $1.83
- KZR $3.53
- 52 Week High
- DARE $9.19
- KZR $8.60
- Technical
- Relative Strength Index (RSI)
- DARE 46.22
- KZR 82.69
- Support Level
- DARE $2.01
- KZR $4.10
- Resistance Level
- DARE $2.28
- KZR $4.45
- Average True Range (ATR)
- DARE 0.10
- KZR 0.31
- MACD
- DARE -0.01
- KZR 0.26
- Stochastic Oscillator
- DARE 25.00
- KZR 95.96
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.